These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24978437)

  • 1. Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.
    Pistelli M; Caramanti M; Biscotti T; Santinelli A; Pagliacci A; De Lisa M; Ballatore Z; Ridolfi F; Maccaroni E; Bracci R; Berardi R; Battelli N; Cascinu S
    Cancers (Basel); 2014 Jun; 6(3):1351-62. PubMed ID: 24978437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
    Ricciardi GR; Adamo B; Ieni A; Licata L; Cardia R; Ferraro G; Franchina T; Tuccari G; Adamo V
    PLoS One; 2015; 10(6):e0128368. PubMed ID: 26039245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
    Tang D; Xu S; Zhang Q; Zhao W
    Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of androgen receptors in triple negative breast carcinomas.
    Mrklić I; Pogorelić Z; Capkun V; Tomić S
    Acta Histochem; 2013 May; 115(4):344-8. PubMed ID: 23031358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
    Abd-Elazeem MA; Abd-Elazeem MA
    Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.
    Riaz N; Idress R; Habib S; Lalani EN
    Front Oncol; 2020; 10():1083. PubMed ID: 32850312
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC).
    Mishra A; Mishra SK; Sharanappa V; Krishnani N; Kumari N; Agarwal G
    Indian J Surg Oncol; 2024 Jun; 15(2):250-257. PubMed ID: 38741650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival.
    Yu L; Yu Q; Xu C; Wang M; Song J; Gao X
    Gland Surg; 2022 Nov; 11(11):1772-1783. PubMed ID: 36518802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.
    McNamara KM; Yoda T; Miki Y; Chanplakorn N; Wongwaisayawan S; Incharoen P; Kongdan Y; Wang L; Takagi K; Mayu T; Nakamura Y; Suzuki T; Nemoto N; Miyashita M; Tamaki K; Ishida T; Ohuchi N; Sasano H
    Cancer Sci; 2013 May; 104(5):639-46. PubMed ID: 23373898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
    Adamo B; Ricciardi GRR; Ieni A; Franchina T; Fazzari C; Sanò MV; Angelico G; Michele C; Tuccari G; Adamo V
    Oncotarget; 2017 Sep; 8(44):76974-76986. PubMed ID: 29100362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
    Choi JE; Kang SH; Lee SJ; Bae YK
    Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
    Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
    Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer.
    Kucukzeybek BB; Bayoglu IV; Kucukzeybek Y; Yıldız Y; Oflazoglu U; Atahan MK; Taskaynatan H; Alacacioglu A; Yigit S; Tarhan MO
    Pol J Pathol; 2018; 69(2):157-168. PubMed ID: 30351863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between androgen receptor status and prognosis in triple negative breast cancer.
    Sunar V; T Dogan H; Sarici F; Ates O; Akin S; Baspinar B; Aksoy S; Altundag K
    J BUON; 2018; 23(5):1325-1330. PubMed ID: 30570854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype.
    McGhan LJ; McCullough AE; Protheroe CA; Dueck AC; Lee JJ; Nunez-Nateras R; Castle EP; Gray RJ; Wasif N; Goetz MP; Hawse JR; Henry TJ; Barrett MT; Cunliffe HE; Pockaj BA
    Ann Surg Oncol; 2014 Feb; 21(2):361-7. PubMed ID: 24046116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
    Dubrava AL; Kyaw PSP; Newman J; Pringle J; Westhuyzen J; La Hera Fuentes G; Shakespeare TP; Sakalkale R; Aherne NJ
    Breast Cancer (Dove Med Press); 2023; 15():359-371. PubMed ID: 37197610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response.
    Mohammed AA; Elsayed FM; Algazar M; Rashed HE; Anter AH
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):563-568. PubMed ID: 32102539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Androgen Receptor Expression in Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    Xu M; Yuan Y; Yan P; Jiang J; Ma P; Niu X; Ma S; Cai H; Yang K
    Clin Breast Cancer; 2020 Aug; 20(4):e385-e396. PubMed ID: 32139270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
    Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
    BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria.
    Haruna M; Daramola AO; Awolola NA; Badr NM; Banjo AAF; Shaaban A
    Ecancermedicalscience; 2022; 16():1452. PubMed ID: 36405944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.